Vitamin D3 Supplementation for Heart Failure Patients



Status:Completed
Conditions:Other Indications, Cardiology, Gastrointestinal
Therapuetic Areas:Cardiology / Vascular Diseases, Gastroenterology, Other
Healthy:No
Age Range:Any
Updated:7/11/2015
Start Date:August 2012
End Date:August 2014
Contact:Heidi D Moretti, MS, RD
Email:hmoretti@saintpatrick.org
Phone:406-327-3117

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Double-Blind, Placebo-Controlled Trial of Vitamin D3 (Cholecalciferol) Supplementation for Heart Failure Patients

The purpose of this study is to determine if treatment with vitamin D3 of 10,000
International Units (IU) daily in vitamin D deficient patients for 6 months will improve B
type natriuretic peptide (BNP), a marker of heart function, compared to placebo. The
investigators also aim to determine if vitamin D helps cardiopulmonary function as evaluated
by cardiopulmonary exercise test (CPX), laboratory values, strength, and quality of life in
patients with stable congestive heart failure (Class II or III).


Inclusion Criteria:

- NYHA Heart Failure Class II or II, stable

- Vitamin D deficiency (32 ng/ml or less)

- No recent medication changes for 3 months

- Females of childbearing age must use effective contraceptive if they are
sexually active

Exclusion Criteria:

- Hypercalcemia

- Nephrolithiases

- Sarcoidosis

- Acute cardiac insufficiency

- Pregnancy

- Breastfeeding

- Any clinically unstable medical condition

- Supplements of greater than or equal to 1000 units of vitamin D per day
We found this trial at
2
sites
The International Heart Institute of Montana
Missoula, Montana 59802
?
mi
from
Missoula, MT
Click here to add this to my saved trials
Saint Patrick Hosptial
Missoula, Montana 59802
?
mi
from
Missoula, MT
Click here to add this to my saved trials